Learning Objectives
Upon completion of this activity, participants should be able to:
- Explain how the 21-gene Recurrence Score assay is used to detect the risk of recurrence in early-stage breast cancer patients
- Discuss how estrogen receptor positivity may play a role as a prognostic factor in early-stage breast cancer
- Describe recommended treatment regimens for premenopausal women with early-stage breast cancer
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.